Dr. Sri Komanduri Joins ECAN Board

CHICAGO (Nov. 30, 2017) – The national non-profit organization, ECAN (Esophageal Cancer Action Network) has elected Sri Komanduri, MD MS FASGE, AGAF to a three-year term on its board of directors.

“It is essential that we continue to develop innovative strategies on all fronts to stop the rise in esophageal cancer in the United States,” said Dr. Komanduri. “Working with visionary organizations such as ECAN to educate the public is critical in reaching this goal.”

A leader in therapeutic endoscopy for the past 14 years with a track record for research in Barrett's esophagus and Esophageal Cancer, Komanduri is the director of interventional endoscopy and medical director of the GI Lab at Northwestern Memorial Hospital.

He also serves as an associate professor of medicine (gastroenterology and hepatology) and surgery (gastrointestinal) at the Feinberg School of Medicine and Northwestern University, where he received Teaching Attending Physician of the Year honors.

Komanduri received his bachelor’s and medical degrees from the University of Miami, followed by a master’s degree in clinical research from Rush Medical College, where he also completed a fellowship in gastroenterology.

Additionally, he completed a fellowship in therapeutic endoscopy at the University of Illinois at Chicago and a residency at Rush University Medical Center.

A fellow in the American Gastroenterological Association (AGA) and American Society of Gastroinstestinal Endoscopy, Komanduri most recently was appointed vice-chair of the AGA’s Center for GI Innovation and Technology. He resides in Downers Grove, Illinois.

About ECAN

ECAN’s mission is to save lives by increasing awareness that reflux disease can cause cancer, promoting early detection, supporting medical innovation to prevent, detect, treat and cure esophageal cancer and linking patients and families to compassionate support. The Baltimore-based national non-profit organization is led by a board of directors of top physicians, business leaders and families touched by esophageal cancer.

ECAN successfully advocated with the National Cancer Institute to include esophageal cancer in its groundbreaking genome mapping project. Through ECAN’s efforts, April has been formally designated as “Esophageal Cancer Awareness Month” across the United States. For more information and the nonprofit’s free, downloadable Guide for Patients about GERD, Barrett’s Esophagus and esophageal cancer, visit www.ECAN.org.